Evidence map›Paper›PMID 42342263›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2026

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

Solène Valery, Nicolas Roche, Thierry Perez, Rachel Nadif

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Solène ValeryUVSQ, Université Paris-Sud, Inserm, Équipe d'Épidémiologie respiratoire intégrative, Université Paris-Saclay, CESP, Villejuif, France solene.valery@inserm.fr.
Nicolas RocheHôpital et Institut Cochin, Service de Pneumologie, APHP Centre-Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-3162-5033
Thierry PerezClinique des Maladies Respiratoires, CHU Lille, Center for Infection and Immunity of Lille (CIIL), Université de Lille, Inserm, CNRS, Institut Pasteur de Lille, U1019, UMR 9017, Lille, France.
Rachel NadifUVSQ, Université Paris-Sud, Inserm, Équipe d'Épidémiologie respiratoire intégrative, Université Paris-Saclay, CESP, Villejuif, France.ORCID https://orcid.org/0000-0003-4938-9339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic dyspnoea is a common and disabling symptom that remains under-investigated as an independent entity at a population level. Most research has focused on dyspnoea as a feature of specific diseases, mainly in high-income countries.

objectiveWe aimed to assess the global prevalence of chronic dyspnoea in population-based studies, and discuss disparities across regions and populations, including low- and middle-income countries.

methodsPubMed, the Cumulative Index to Nursing and Allied Health Literature, Google Scholar and Embase were searched using dedicated algorithms. The literature up to 2 September 2025 was reviewed; studies reporting chronic dyspnoea prevalence in general populations were included, and those restricted to older adults or specific subgroups were excluded.

results68 studies met the inclusion criteria. Although limited in scope, the modified Medical Research Council scale was the most frequently used tool. Prevalence varied widely, from 5-10% in Europe to >25% in South Asia. Differences were observed between high- and low-income countries, between low-income countries, and within the same country over time. Observed disparities stem from variations in definitions, assessment methods, socioeconomic conditions, possible genetic predispositions, environmental exposures, and lifestyle factors. Chronic dyspnoea has been associated with demographic, behavioural and health-related factors including sex, age, weight, physical activity and comorbidities.

conclusionThere are major global disparities in the prevalence of chronic dyspnoea between and within countries at different income levels. There is a critical need for targeted, country-specific studies, particularly in low- and middle-income countries, to support equitable interventions, and for newly designed studies using more detailed and comprehensive measures of dyspnoea.

Indexed as

DyspneaGlobal HealthHealth Status DisparitiesChronic DiseaseHumansPrevalenceRisk FactorsSocioeconomic Disparities in Health

Identifiers

PMID42342263
PMCPMC13291833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.